GlassScriptPhysician profile
David S Buggay
NPI 1134197171
$14,651.32
in general payments reported to CMS, 2019-2025
39 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $126 · 2021: $7,435 · 2022: $535 · 2023: $686 · 2024: $4,350 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,314 · Travel and Lodging: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,314.03 |
| Travel and Lodging | $2,963.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $3,887.10 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $3,071.86 | 2024-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Pulse |
| Spineology INC. | $2,154.58 | 2021-2022 | |
| Prime Surgical, LLC | $1,200.00 | 2021 | |
| Depuy Synthes Sales INC. | $650.44 | 2019-2025 | Vivigen Mis Delivery System, Fibergraft Bg Morsels, Acf |
| Providence Medical Technology, INC. | $454.15 | 2020-2025 | |
| Curiteva, INC. | $448.38 | 2024 | |
| Centinel Spine, LLC | $342.04 | 2024 | Prodisc L |
| Nuvasive, INC. | $281.83 | 2019-2023 | Alif |
| Kuros Biosciences USA, INC | $185.71 | 2025 | Magnetos |
| Anika Therapeutics, INC. | $157.30 | 2021 | |
| Stryker Corporation | $157.13 | 2020-2023 | Mako |
| Orthalign INC | $156.19 | 2025 | Orthalign Plus |
| Innovation Technologies INC | $143.56 | 2023 | Irrisept |
| Si-Bone, INC. | $141.97 | 2020-2024 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carlsmed, INC. | $139.76 | 2021-2024 | Aprevo |
| Ossdsign USA Incorporated | $134.34 | 2025 | Ossdsign Catalyst |
| Boston Scientific Corporation | $134.09 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Ethicon US, LLC | $79.11 | 2025 | Stratafix, Vistaseal, Dermabond Prineo |
| Pacira Pharmaceuticals Incorporated | $78.41 | 2023-2024 | Exparel, Zilretta, Iovera |
| Biocomposites INC | $65.02 | 2024 | |
| Smith+Nephew, INC. | $63.38 | 2019-2023 | Journey II |
| Surgalign Spine Technologies, INC. | $60.52 | 2021 | |
| Ferring Pharmaceuticals INC. | $58.56 | 2019-2021 | |
| Medtronic, INC. | $50.38 | 2024 | Intellis Adaptivestim |
| Bioventus LLC | $46.53 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Wenzel Spine, INC. | $41.67 | 2019 | |
| Convatec INC. | $40.30 | 2019-2024 | |
| Ermi LLC | $39.47 | 2021-2022 | |
| Exactech, INC. | $26.91 | 2019 | |
| Baudax Bio INC. | $22.07 | 2021 | |
| Amgen INC. | $21.22 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $20.21 | 2025 | |
| Orthofix Medical, INC. | $18.68 | 2023 | Physio-Stim |
| Avanos Medical | $17.94 | 2025 | Trivisc Sodium Hyaluronate |
| Horizon Therapeutics Plc | $17.40 | 2023 | Krystexxa |
| Cumberland Pharmaceuticals, INC. | $15.61 | 2019 | |
| Kerecis Limited | $14.23 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pfizer INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Buggay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.